These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30773199)

  • 1. Optimization of Infrared Microscopy to Assess Secondary Structure of Insulin Molecules Within Individual Subvisible Particles in Aqueous Formulations.
    Schack MM; Møller EH; Friderichsen AV; Carpenter JF; Rades T; Groenning M
    J Pharm Sci; 2019 Mar; 108(3):1117-1129. PubMed ID: 30773199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
    Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N
    Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products.
    Zhang L; Shi S; Antochshuk V
    J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Platform for Preparing Homogeneous Proteinaceous Subvisible Particles With Distinct Morphologies.
    Schack MM; Møller EH; Carpenter JF; Rades T; Groenning M
    J Pharm Sci; 2018 Jul; 107(7):1842-1851. PubMed ID: 29574228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Quantification of Protein Particles in High-Concentration Antibody Formulations.
    Wu H; Randolph TW
    J Pharm Sci; 2019 Mar; 108(3):1110-1116. PubMed ID: 30773198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Differentiation of Protein Aggregates From Other Subvisible Particles in Viscous Mixtures Through Holographic Characterization.
    Winters A; Cheong FC; Odete MA; Lumer J; Ruffner DB; Mishra KI; Grier DG; Philips LA
    J Pharm Sci; 2020 Aug; 109(8):2405-2412. PubMed ID: 32439328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator.
    Patel AR; Lau D; Liu J
    Anal Chem; 2012 Aug; 84(15):6833-40. PubMed ID: 22794526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing ensemble polymorphism and single aggregate structural heterogeneity in insulin amyloid self-assembly.
    De Luca G; Fennema Galparsoro D; Sancataldo G; Leone M; Foderà V; Vetri V
    J Colloid Interface Sci; 2020 Aug; 574():229-240. PubMed ID: 32325288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.
    Corvari V; Narhi LO; Spitznagel TM; Afonina N; Cao S; Cash P; Cecchini I; DeFelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Weiskopf A; Wuchner K
    Biologicals; 2015 Nov; 43(6):457-73. PubMed ID: 26324466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy.
    Narhi LO; Corvari V; Ripple DC; Afonina N; Cecchini I; Defelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Spitznagel TM; Weiskopf A; Wuchner K
    J Pharm Sci; 2015 Jun; 104(6):1899-1908. PubMed ID: 25832583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy.
    Yang H; Yang S; Kong J; Dong A; Yu S
    Nat Protoc; 2015 Mar; 10(3):382-96. PubMed ID: 25654756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FT-IR versus EC-QCL spectroscopy for biopharmaceutical quality assessment with focus on insulin-total protein assay and secondary structure analysis using attenuated total reflection.
    Delbeck S; Heise HM
    Anal Bioanal Chem; 2020 Jul; 412(19):4647-4658. PubMed ID: 32488383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of poly(ethylene glycol)-modified horseradish peroxidase in organic solvents: infrared amide I spectral changes upon protein dehydration are largely caused by protein structural changes and not by water removal per se.
    Al-Azzam W; Pastrana EA; Ferrer Y; Huang Q; Schweitzer-Stenner R; Griebenow K
    Biophys J; 2002 Dec; 83(6):3637-51. PubMed ID: 12496131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the rapid and nondestructive identification of TCM formula particles by FTIR].
    Tang JM; Sun SQ; Yuan ZM; Qin Z
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 May; 24(5):554-6. PubMed ID: 15769044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions.
    Daniels AL; Randolph TW
    J Pharm Sci; 2018 May; 107(5):1313-1321. PubMed ID: 29409840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Convolutional Neural Network Analysis of Flow Imaging Microscopy Data to Classify Subvisible Particles in Protein Formulations.
    Calderon CP; Daniels AL; Randolph TW
    J Pharm Sci; 2018 Apr; 107(4):999-1008. PubMed ID: 29269269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.